Relations between patient characteristics and PRU in the PSG group
| Clinical and Laboratory Variablesa | P Value | PRU |
|---|---|---|
| Sex (M) | .18 | 129.6 ± 49.0 vs 130.3 ± 68.0 |
| Age (<65 yr) | .17 | 122.6 ± 59.4 vs 148.0 ± 65.4 |
| Body weight (<60 kg) | <.001 | 102.3 ± 54.5 vs 156.7 ±55.2 |
| Hypertension (no) | .20 | 120.6 ± 62.2 vs 142.0 ± 60.1 |
| Diabetes mellitus (yes) | .31 | 127.5 ± 63.8 vs 157.0 ± 37.6 |
| Statin use (yes) | .02 | 109.5 ± 42.8 vs 148.2 ± 72.3 |
| Smoking status (current or past smoker) | <.001 | 77.4 ± 26.1 vs 148.2 ± 61.5 |
| Alcohol intake (yes) | .24 | 110.6 ± 106.5 vs 135.0 ± 50.6 |
| Hematocrit level (<38%) | .84 | 128.5 ± 69.4 vs 131.8 ± 55.0 |
| Platelet count (<227 × 103) | .58 | 125.6 ± 61.5 vs 135.0 ± 63.0 |
| HDL cholesterol level (<40 mg/dL) | .89 | 125.6 ± 50.1 vs 129.2 ± 64.2 |
| LDL cholesterol level (≥130 mg/dL) | <.001 | 69.5 ± 21.1 vs 145.9 ±59.1 |
Note:—HDL indicates high-density lipoprotein; LDL, low-density lipoprotein.
↵a A group of patients denoted within the parentheses showed decreased residual platelet activity.